Gynecological cancers affect over 4,000 women annually in Serbia

More than 4,000 women in Serbia are diagnosed with gynecological cancers annually, including ovarian, cervical, and endometrial cancers. Medical experts warn that these diseases often lack clear early symptoms, frequently leading to diagnoses only after the cancer has reached an advanced stage.

Professor Dr. Aleksandar Stefanović of the Clinical Center of Serbia noted that over 70 percent of ovarian cancer patients are already in stage three or four at the time of diagnosis. While surgery remains a primary treatment, advancements in genetic testing and targeted therapies, such as PARP inhibitors for HRD-positive tumors, have improved outcomes for approximately 50 percent of newly diagnosed ovarian cancer patients.

However, access to innovative treatments varies significantly between different types of gynecological malignancies. While immunotherapy and combination therapies offer new possibilities for advanced endometrial cancer, organizations like ‘Progovori’ emphasize that early diagnosis through regular screenings remains the most critical factor in reducing mortality rates, particularly for cervical cancer.